These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35065992)
1. Development of quercetin-loaded PVCL-PVA-PEG micelles and application in inhibiting tumor angiogenesis through the PI3K/Akt/VEGF pathway. Qi X; Gao C; Yin C; Fan J; Wu X; Di G; Wang J; Guo C Toxicol Appl Pharmacol; 2022 Feb; 437():115889. PubMed ID: 35065992 [TBL] [Abstract][Full Text] [Related]
2. Improved anticancer activity of betulinic acid on breast cancer through a grafted copolymer-based micelles system. Qi X; Gao C; Yin C; Fan J; Wu X; Guo C Drug Deliv; 2021 Dec; 28(1):1962-1971. PubMed ID: 34565273 [TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of a novel drug delivery: Soluplus Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models. Wu Q; Deng S; Li L; Sun L; Yang X; Liu X; Liu L; Qian Z; Wei Y; Gong C Nanoscale; 2013 Dec; 5(24):12480-93. PubMed ID: 24165931 [TBL] [Abstract][Full Text] [Related]
5. Soluplus(®) micelles as a potential drug delivery system for reversal of resistant tumor. Jin X; Zhou B; Xue L; San W Biomed Pharmacother; 2015 Feb; 69():388-95. PubMed ID: 25661387 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade. Mishra GP; Nguyen D; Alani AW Mol Pharm; 2013 May; 10(5):2071-8. PubMed ID: 23590802 [TBL] [Abstract][Full Text] [Related]
7. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study. Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878 [TBL] [Abstract][Full Text] [Related]
9. BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway. Banskota S; Gautam J; Regmi SC; Gurung P; Park MH; Kim SJ; Nam TG; Jeong BS; Kim JA PLoS One; 2016; 11(1):e0148133. PubMed ID: 26824764 [TBL] [Abstract][Full Text] [Related]
10. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253 [TBL] [Abstract][Full Text] [Related]
11. The epigallocatechin gallate derivative Y Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759 [TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis. Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688 [TBL] [Abstract][Full Text] [Related]
13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
14. Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment. Singh J; Mittal P; Vasant Bonde G; Ajmal G; Mishra B Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S546-S555. PubMed ID: 30322273 [TBL] [Abstract][Full Text] [Related]
15. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy. Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426 [TBL] [Abstract][Full Text] [Related]
16. Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system. Zhang Z; Cui C; Wei F; Lv H Drug Dev Ind Pharm; 2017 Aug; 43(8):1276-1282. PubMed ID: 28358225 [TBL] [Abstract][Full Text] [Related]
17. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Fang J; Ding M; Yang L; Liu LZ; Jiang BH Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033 [TBL] [Abstract][Full Text] [Related]
18. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis. Zhu GS; Tang LY; Lv DL; Jiang M Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071 [TBL] [Abstract][Full Text] [Related]
19. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103 [TBL] [Abstract][Full Text] [Related]
20. CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells. Liu GT; Chen HT; Tsou HK; Tan TW; Fong YC; Chen PC; Yang WH; Wang SW; Chen JC; Tang CH Oncotarget; 2014 Nov; 5(21):10718-31. PubMed ID: 25301739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]